A detailed history of Loomis Sayles & CO L P transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Loomis Sayles & CO L P holds 548 shares of EW stock, worth $37,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares
548
Previous 538 1.86%
Holding current value
$37,132
Previous $50,000 28.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $597 - $937
10 Added 1.86%
548 $36,000
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $927 - $1,037
11 Added 2.09%
538 $50,000
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $435 - $573
-6 Reduced 1.13%
527 $50,000
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $25,609 - $32,270
-415 Reduced 43.78%
533 $41,000
Q3 2023

Nov 09, 2023

BUY
$69.28 - $93.38 $6,443 - $8,684
93 Added 10.88%
948 $66,000
Q2 2023

Aug 11, 2023

BUY
$81.41 - $94.33 $33,215 - $38,486
408 Added 91.28%
855 $81,000
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $11,658 - $13,268
-157 Reduced 25.99%
447 $37,000
Q4 2022

Feb 10, 2023

BUY
$68.3 - $87.44 $30,598 - $39,173
448 Added 287.18%
604 $45,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $72,403 - $94,307
-879 Reduced 84.93%
156 $13,000
Q2 2022

Aug 05, 2022

SELL
$86.5 - $128.27 $19,289 - $28,604
-223 Reduced 17.73%
1,035 $98,000
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $2,345 - $2,951
23 Added 1.86%
1,258 $148,000
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $1,341 - $1,676
-16 Reduced 1.28%
1,235 $128,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $48,391 - $64,714
841 Added 205.12%
1,251 $86,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $29,397 - $33,656
410 New
410 $96,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.